In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Google gave an update on various aspects of its health-related R&D at its annual event The Check Up, including a new collection of artificial intelligence (AI) models intended to support drug ...

Traditionally, individuals asked health questions of their primary health care provider. Confidence in that provider as a ...

Most U.S. adults find the information to be at least somewhat reliable, new research shows. But experts say there is ...

Discover Grok 4, the AI model redefining advanced reasoning and problem-solving. Explore its potential, challenges, and ...

The global agentic AI in healthcare market is set to witness a growth rate of 35-40% in the next 5 years. Increasing demand ...

AI startups (>27K), tools (>70K), and GitHub repos highlight proliferation. Patents in computing/AI are booming, signaling a ...

PATH has launched the largest study of its kind in Africa, recruiting 9,000 participants to test whether AI can help primary ...